Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug–protein dissociation rates
Authors:
- 1 April 2011
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1218 (15) , 2072-2078
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatographyJournal of Chromatography B, 2010
- Evaluation of silica monoliths in affinity microcolumns for high‐throughput analysis of drug–protein interactionsJournal of Separation Science, 2009
- Noncompetitive peak decay analysis of drug–protein dissociation by high‐performance affinity chromatographyJournal of Separation Science, 2009
- Kinetic studies of biological interactions by affinity chromatographyJournal of Separation Science, 2009
- Measurement of Drug−Protein Dissociation Rates by High-Performance Affinity Chromatography and Peak ProfilingAnalytical Chemistry, 2009
- Studies of imipramine binding to human serum albumin by high-performance affinity chromatographyJournal of Chromatography B, 2009
- Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albuminJournal of Chromatography A, 2009
- Characterization of drug–protein interactions in blood using high‐performance affinity chromatographyJournal of Separation Science, 2009
- Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC)Journal of Chromatography B, 2008
- Development of an affinity silica monolith containing human serum albumin for chiral separationsJournal of Pharmaceutical and Biomedical Analysis, 2007